Eva Renee Barnett - 15 Oct 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Financial Officer
Signature: /s/ Eva Renee Barnett
Issuer symbol: IMVT
Transactions as of: 15 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 18 Oct 2021, 17:11:11 UTC
Previous filing: 05 Oct 2021
Next filing: 11 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+143,000	+240%	$0.000000	202,500	15 Oct 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+333,000		$0.000000	333,000	15 Oct 2021	Common Stock	333,000	$8.72	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	The RSUs vest over four years, with 25% of the RSUs vesting on October 4, 2022 and the remainder of the RSUs vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3	Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 4, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.